European Medicines Agency publishes report on patient recruitment and geographical location of clinical trials
Clinical Trials Thursday, April 18th, 2013European Medicines Agency: April 9, 2013
Almost 62% of the patients in pivotal trials submitted in marketing-authorisation applications (MAAs) to the European Medicines Agency between January 2005 and December 2011 were recruited outside of the European Economic Area (EEA) and Switzerland, according to an analysis performed by the Agency.
The report on clinical trials submitted in MAAs to the European Medicines Agency, published today, provides an overview of the distribution of the numbers of patients, investigator sites and pivotal clinical trials included in MAAs submitted to the Agency, as well as the number and location of sites that were inspected. Read more
